✦ LIBER ✦

THE IMMIDIATE ANTIPLATELET EFFECT OF PRASUGREL VERSUS CLOPIDOGREL IN PATIENTS UNDERGOING PRIMARY ANGIOPLASTY FOR ST-ELEVATION MYOCARDIAL INFARCTION – IMPLICATIONS FOR REPERFUSION

✍ Scribed by Roy Beigel; Paul Fefer; Noam Fink; Avishay Grupper; David Varon; Hanoch Hod; Shlomi Matetzky

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

THE ANTI-PLATELET EFFECT OF PRASUGREL AS

✍ Roy Beigel; Romana Herscovici; Paul Fefer; Hanoch Hod; Shlomi Matetzky 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Usefulness of Pretreatment With High-Dos

✍ Paul Fefer; Hanoch Hod; Haim Hammerman; Amit Segev; Roy Beinart; Valentina Boyko 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 421 KB

The loading dose of clopidogrel in patie

✍ Gen-Min Lin; Chih-Lu Han 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 76 KB

THE ANTI-PLATELET EFFECT OF PRE-TREATMEN

✍ Roy Beigel; Paul Fefer; Boris Shenkman; Noam Fink; Elad Asher; Hanoch Hod; Shlom 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 239 KB

Comparison of 600 Versus 300-mg Clopidog

✍ Fabio Mangiacapra; Olivier Muller; Argyrios Ntalianis; Catalina Trana; Guy R. He 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 355 KB

Comparison of 600 Versus 300-mg Clopidog

✍ Gen-Min Lin; Yi-Hwei Li 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 73 KB